Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 8
2020 69
2021 34
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

69 results

Results by year

Filters applied: . Clear all
Page 1
Minimally Invasive Complete Response Assessment of the Breast After Neoadjuvant Systemic Therapy for Early Breast Cancer (MICRA trial): Interim Analysis of a Multicenter Observational Cohort Study.
van Loevezijn AA, van der Noordaa MEM, van Werkhoven ED, Loo CE, Winter-Warnars GAO, Wiersma T, van de Vijver KK, Groen EJ, Blanken-Peeters CFJM, Zonneveld BJGL, Sonke GS, van Duijnhoven FH, Vrancken Peeters MTFD. van Loevezijn AA, et al. Ann Surg Oncol. 2021 Jun;28(6):3243-3253. doi: 10.1245/s10434-020-09273-0. Epub 2020 Dec 2. Ann Surg Oncol. 2021. PMID: 33263830 Free PMC article.
Breast cancer mortality trends in Peruvian women.
Torres-Roman JS, Martinez-Herrera JF, Carioli G, Ybaseta-Medina J, Valcarcel B, Pinto JA, Aguilar A, McGlynn KA, La Vecchia C. Torres-Roman JS, et al. BMC Cancer. 2020 Dec 1;20(1):1173. doi: 10.1186/s12885-020-07671-x. BMC Cancer. 2020. PMID: 33261561 Free PMC article.
Correction to: Impact of a combined multimodal-aerobic and multimodal intervention compared to standard aerobic treatment in breast cancer survivors with chronic cancer-related fatigue - results of a three-armed pragmatic trial in a comprehensive cohort design.
Kröz M, Reif M, Glinz A, Berger B, Nikolaou A, Zerm R, Brinkhaus B, Girke M, Büssing A, Gutenbrunner C; CRF-2 study group. Kröz M, et al. BMC Cancer. 2020 Dec 1;20(1):1174. doi: 10.1186/s12885-020-07679-3. BMC Cancer. 2020. PMID: 33261571 Free PMC article.
Treatment variation in early breast cancer in the UK.
Dodwell D, Jauhari Y, Gathani T, Cromwell D, Gannon M, Clements K, Horgan K. Dodwell D, et al. BMJ. 2020 Dec 1;371:m4237. doi: 10.1136/bmj.m4237. BMJ. 2020. PMID: 33262116 No abstract available.
Treatment strategies for breast cancer brain metastases.
Bailleux C, Eberst L, Bachelot T. Bailleux C, et al. Br J Cancer. 2021 Jan;124(1):142-155. doi: 10.1038/s41416-020-01175-y. Epub 2020 Nov 30. Br J Cancer. 2021. PMID: 33250512 Free PMC article. Review.
RON signalling promotes therapeutic resistance in ESR1 mutant breast cancer.
Dustin D, Gu G, Beyer AR, Herzog SK, Edwards DG, Lin H, Gonzalez TL, Grimm SL, Coarfa C, Chan DW, Kim BJ, De La O JP, Ellis MJ, Liu D, Li S, Welm AL, Fuqua SAW. Dustin D, et al. Br J Cancer. 2021 Jan;124(1):191-206. doi: 10.1038/s41416-020-01174-z. Epub 2020 Dec 1. Br J Cancer. 2021. PMID: 33257837 Free PMC article.
69 results